Real-world chemotherapy treatment patterns in metastatic non-small cell lung cancer: Are patients undertreated?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world chemotherapy treatment patterns in metastatic non-small cell lung cancer: Are patients undertreated?

Published:2015-04-17 Issue:15 Volume:121 Page:2562-2569
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sacher Adrian G.¹²³,Le Lisa W.¹⁴,Lau Anthea¹⁴,Earle Craig C.³⁵,Leighl Natasha B.¹³

Affiliation:

1. Division of Medical Oncology, Princess Margaret Cancer Centre; University Health Network; Toronto Canada

2. Lowe Center for Thoracic Oncology; Dana-Farber Cancer Institute, Harvard Medical School; Boston Massachusetts

3. Faculty of Medicine; University of Toronto; Toronto Canada

4. Department of Biostatistics, Princess Margaret Cancer Center; University Health Network; Toronto Canada

5. Institute for Clinical Evaluative Sciences; Toronto Canada

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29386/fullpdf

Reference26 articles.

1. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients;Le Chevalier;J Clin Oncol,1994

2. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy;Shepherd;J Clin Oncol,2000

3. Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial;Belani;Lung Cancer,2006

4. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy;Hanna;J Clin Oncol,2004

5. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer;Scagliotti;J Clin Oncol,2008

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal Study of Advanced Non-Small Cell Lung Cancer with Initial Durable Clinical Benefit to Immunotherapy: Strategies for Anti-PD-1/PD-L1 Continuation beyond Progression;Cancers;2023-11-26

2. Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in Australia;PharmacoEconomics;2023-06-25

3. A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase (ALK) Inhibitors in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC);PharmacoEconomics;2023-06-03

4. Is cancer stage data missing completely at random? A report from a large population-based cohort of non-small cell lung cancer;Frontiers in Oncology;2023-04-04

5. Post-progression survival in advanced non-small cell lung cancer treated with anti-PD-1/PDL-1 monotherapy: progression after durable clinical benefit versus primary resistance;2023-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3